International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7710609
Original Article
Correlation of C- reactive protein and Blood culture in Neonatal Sepsis in a Tertiary Health Care Centre of South India
 ,
Published
March 9, 2023
Abstract
Introduction: Neonatal sepsis is a common cause of neonatal morbidity and mortality. Gold standard method for diagnosing neonatal sepsis is blood culture but it is time consuming, requires well equipped laboratory and trained laboratory personnel. Serum C-Reactive Protein (CRP) is an acute phase reactant, which is released in response to the inflammatory reaction. CRP levels reflect the individual's association between microbial infection. This study is conducted for evaluation of CRP role in the blood as early marker in neonatal sepsis and to find its correlation with blood culture. Methodology: This study was conducted in microbiology laboratory from Nov 2022 to Feb 2023 to evaluate the correlation of C-Reactive Protein and Blood Culture in Neonatal Sepsis. Suspected neonatal sepsis cases in the department of Pediatrics were included in the study. After taking aseptic precautions, 1-2 ml of blood was collected and inoculated into blood culture bottle containing 5 ml of Brain Heart Infusion Broth. CRP level was detected by Latex Agglutination Card test. Results: Out of total 350 samples, 246 were from female and 104 were from male. Among350 samples tested,43 were blood culture positive and 156 were CRP positive. All blood culture positive samples were CRP positive also. Among the blood culture negative samples, 113 were CRP positive. Conclusion: Early diagnosis of neonatal sepsis with the help of biomarkers like C-Reactive Protein plays a major role in reducing mortality & morbidity among the neonates.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1190 Views
431 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved